๐
Bildyos
denosumab
Bone Resorption;Osteoporosis, Postmenopausal;Osteoporosis
โ
Authorised
Biosimilar
โ
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
Treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures. Inpostmenopausal women, denosumab significantly reduces the risk of vertebral, non-vertebral and hipfractures. Treatment of bone loss associated with hormone ablation in men with prostate cancer at increased riskof fractures. In men with prostate cancer receiving hormone ablation, denosumabsignificantly reduces the risk of vertebral fractures. Treatment of bone loss associated with long-term systemic glucocorticoid therapy in adult patients atincreased risk of fracture.
โ ๏ธ Patient safety
No
Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/bildyos